Pharmaceutical Stocks List


Related Industries: Asset Management Biotechnology Business Services Chemicals Data Storage Diagnostics & Research Diversified Industrials Drug Manufacturers - General Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Farm & Construction Equipment Health Information Services Household & Personal Products Information Technology Services Internet Content & Information Lumber & Wood Production Medical Devices Medical Distribution Medical Instruments & Supplies Packaging & Containers Pharmaceutical Retailers Pharmaceutical Retailers Pollution & Treatment Controls Security & Protection Services Semiconductor Equipment & Materials Software - Application Specialty Chemicals Specialty Finance Steel Waste Management

Pharmaceutical Stocks Recent News

Date Stock Title
Apr 23 ABBV Allergan Aesthetics Invites Consumers to Be the Face of BOTOX® Cosmetic (onabotulinumtoxinA) and Their Other Biggest Brands
Apr 22 ABBV AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Apr 22 ABBV EU regulators approve Pfizer antibiotic Emblaveo
Apr 22 ABBV Buying the Dip in These 3 Undervalued Dividend Stocks
Apr 21 ABBV Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 19 ABBV The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Apr 19 ABBV Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
Apr 19 ABBV Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Apr 19 ALVO Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
Apr 19 ALVO Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Apr 18 ABBV Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
Apr 18 ABBV AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
Apr 18 ABBV Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
Apr 18 ABBV AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition
Apr 18 ABBV Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Apr 18 ALPN Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Apr 18 ABBV AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
Apr 18 ABBV Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Apr 17 ABBV AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
Apr 17 ABBV CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Pharmaceutical

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags